Experiment: 9FZM

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.5 mM [U-100% 13C; U-100% 15N] B domain of protein A	90% H2O/10% D2O	150 mM	6.5	1 bar	288.15	Bruker AVANCE III 800
2	2D 1H-13C HSQC aliphatic	0.5 mM [U-100% 13C; U-100% 15N] B domain of protein A	90% H2O/10% D2O	150 mM	6.5	1 bar	288.15	Bruker AVANCE III 800
3	2D 1H-13C HSQC aromatic	0.5 mM [U-100% 13C; U-100% 15N] B domain of protein A	90% H2O/10% D2O	150 mM	6.5	1 bar	288.15	Bruker AVANCE III 800
4	3D HNCACB	0.5 mM [U-100% 13C; U-100% 15N] B domain of protein A	90% H2O/10% D2O	150 mM	6.5	1 bar	288.15	Bruker AVANCE III 800
5	HN(CO)CACB	0.5 mM [U-100% 13C; U-100% 15N] B domain of protein A	90% H2O/10% D2O	150 mM	6.5	1 bar	288.15	Bruker AVANCE III 800
6	3D HCCH-TOCSY	0.5 mM [U-100% 13C; U-100% 15N] B domain of protein A	90% H2O/10% D2O	150 mM	6.5	1 bar	288.15	Bruker AVANCE III 800
7	3D 1H-15N TOCSY	0.5 mM [U-100% 13C; U-100% 15N] B domain of protein A	90% H2O/10% D2O	150 mM	6.5	1 bar	288.15	Bruker AVANCE III 800
8	3D 1H-15N NOESY	0.5 mM [U-100% 13C; U-100% 15N] B domain of protein A	90% H2O/10% D2O	150 mM	6.5	1 bar	288.15	Bruker AVANCE III 800
9	3D 1H-13C NOESY aliphatic	0.5 mM [U-100% 13C; U-100% 15N] B domain of protein A	90% H2O/10% D2O	150 mM	6.5	1 bar	288.15	Bruker AVANCE III 800
10	3D 1H-13C NOESY aromatic	0.5 mM [U-100% 13C; U-100% 15N] B domain of protein A	90% H2O/10% D2O	150 mM	6.5	1 bar	288.15	Bruker AVANCE III 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	800

NMR Refinement
Method	Details	Software
simulated annealing		CNS

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	20
Conformers Submitted Total Number	10
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	chemical shift assignment	NMRViewJ		Johnson
2	structure calculation	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
5	structure calculation	ARIA		Linge, O'Donoghue and Nilges
3	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
4	peak picking	NMRViewJ		Johnson
6	geometry optimization	TALOS+		Cornilescu
7	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.